Kinase assays
•Download as PPT, PDF•
0 likes•23 views
Kinases are a large family contains 518 members which represent one of the most important and largest superfamilies of drugable targets and a major research field for both the pharmaceutical industry and academic research. https://www.creative-biogene.com/Services/Drug-Discovery-Services/Kinase-Screening-Assays.html
Report
Share
Report
Share
Recommended
Host Cell Protein Analysis by Mass Spectrometry | KBI Biopharma
Host Cell Protein Analysis by Mass Spectrometry. Originally presented at the 2018 Sciex Users Meeting by Michael J Nold, Ph.D., Mass Spectrometry Core Facility at KBI Biopharma.
Webinar: Evaluating Viral Clearance for Continuous Processes
Participate in the interactive webinar now: http://bit.ly/ViralClearanceWebinar
Is viral clearance a hurdle to implementing continuous processing? We’ll share virus spiking alternatives that may pave the way for effectively evaluating viral clearance by chromatography steps in a continuous process.
Explore our webinar library: www.emdmillipore.com/webinars
Host Cell Protein Analysis - Measuring the Forest, or Counting theTrees
An issue with the Host Cell Protein assay is that it has a tendency to have a non-linear response to sample dilution. This presentation investigates the source of that issue and what, if anything, might be done about it.
Octet Potency Assay: Development, Qualification and Validation Strategies
Octet Potency Assay: Development, Qualification and
Validation Strategies
Carson Cameron, Brendan Peacor, Nathan Oien, Andrew Cheeseman, and Jimmy Smedley, KBI Biopharma, Durham, NC
John Laughlin, and David O. Apiyo, ForteBio, Fremont, CA
1072729 pp gef_service_core_0512
The QIAGEN Service Core provides a full service for genomic and expression analysis using cutting-edge tools. It accepts various sample types and performs experiments, such as pathway-focused analysis, whole genome analysis, and real-time PCR, using reagents and equipment. This allows customers to save costs by avoiding investing in their own resources and saves time by outsourcing experimental work. A variety of nucleic acid and data analysis services are available.
Webinar: Benefits of Monodisperse Activated PEGs in ADC Development
Watch the webinar here: http://bit.ly/PEGsWebinar
As the field of antibody-drug conjugation chemistry has advanced, the use of linkers to impart "drugability" has also been growing. Recent literature shows a variety of linear and branched monodisperse PEGs being called on to modify the PK/PD profile of some of the most active but lipophilic payloads. In this webinar, we will survey the types of PEGs that are used in ADCs and give examples of successful implementation to change the biophysical properties of the construct. In addition, we will focus on PEGs and why activated PEGs are widely used to improve the pharmacokinetics of drugs (such as pegylated proteins, peptides etc.). Raw materials used in this field may have a variety of polydispersity. However, when it comes to the use of activated PEGs as linkers for ADCs, the requirements are significantly higher. Therefore, the choice and control of the PEG linker is crucial for the successful development and accelerated time to market for your ADC.
This webinar addresses critical success factors such as:
• Survey of current PEG enhanced ADCs
• Why PEGs are used designing ADCs
• Critical parameters for aPEGs used as linkers
• Requirements in terms of analytical capabilities
Accelerate Delivery of High Producing Cell Lines
Merck KGaA provides cell line development and manufacturing services to support customers' biologics drug development programs, with over 30 years of experience developing over 250 cell lines. They have extensive expertise in cell line development, process development, analytical testing, and GMP manufacturing across multiple sites globally. The document highlights some of Merck KGaA's capabilities and case studies, including their approaches to optimizing cell line development techniques and processes like mini-pool screening and signal peptide selection to generate high producing cell lines.
To assess the effect of formalin on genomic DNA and assay performance for som...
What is the impact of assay failure in your laboratory and how do you monitor for it?
Application of Companion Diagnostics - driving better treatment for cancer patients
Recommended
Host Cell Protein Analysis by Mass Spectrometry | KBI Biopharma
Host Cell Protein Analysis by Mass Spectrometry. Originally presented at the 2018 Sciex Users Meeting by Michael J Nold, Ph.D., Mass Spectrometry Core Facility at KBI Biopharma.
Webinar: Evaluating Viral Clearance for Continuous Processes
Participate in the interactive webinar now: http://bit.ly/ViralClearanceWebinar
Is viral clearance a hurdle to implementing continuous processing? We’ll share virus spiking alternatives that may pave the way for effectively evaluating viral clearance by chromatography steps in a continuous process.
Explore our webinar library: www.emdmillipore.com/webinars
Host Cell Protein Analysis - Measuring the Forest, or Counting theTrees
An issue with the Host Cell Protein assay is that it has a tendency to have a non-linear response to sample dilution. This presentation investigates the source of that issue and what, if anything, might be done about it.
Octet Potency Assay: Development, Qualification and Validation Strategies
Octet Potency Assay: Development, Qualification and
Validation Strategies
Carson Cameron, Brendan Peacor, Nathan Oien, Andrew Cheeseman, and Jimmy Smedley, KBI Biopharma, Durham, NC
John Laughlin, and David O. Apiyo, ForteBio, Fremont, CA
1072729 pp gef_service_core_0512
The QIAGEN Service Core provides a full service for genomic and expression analysis using cutting-edge tools. It accepts various sample types and performs experiments, such as pathway-focused analysis, whole genome analysis, and real-time PCR, using reagents and equipment. This allows customers to save costs by avoiding investing in their own resources and saves time by outsourcing experimental work. A variety of nucleic acid and data analysis services are available.
Webinar: Benefits of Monodisperse Activated PEGs in ADC Development
Watch the webinar here: http://bit.ly/PEGsWebinar
As the field of antibody-drug conjugation chemistry has advanced, the use of linkers to impart "drugability" has also been growing. Recent literature shows a variety of linear and branched monodisperse PEGs being called on to modify the PK/PD profile of some of the most active but lipophilic payloads. In this webinar, we will survey the types of PEGs that are used in ADCs and give examples of successful implementation to change the biophysical properties of the construct. In addition, we will focus on PEGs and why activated PEGs are widely used to improve the pharmacokinetics of drugs (such as pegylated proteins, peptides etc.). Raw materials used in this field may have a variety of polydispersity. However, when it comes to the use of activated PEGs as linkers for ADCs, the requirements are significantly higher. Therefore, the choice and control of the PEG linker is crucial for the successful development and accelerated time to market for your ADC.
This webinar addresses critical success factors such as:
• Survey of current PEG enhanced ADCs
• Why PEGs are used designing ADCs
• Critical parameters for aPEGs used as linkers
• Requirements in terms of analytical capabilities
Accelerate Delivery of High Producing Cell Lines
Merck KGaA provides cell line development and manufacturing services to support customers' biologics drug development programs, with over 30 years of experience developing over 250 cell lines. They have extensive expertise in cell line development, process development, analytical testing, and GMP manufacturing across multiple sites globally. The document highlights some of Merck KGaA's capabilities and case studies, including their approaches to optimizing cell line development techniques and processes like mini-pool screening and signal peptide selection to generate high producing cell lines.
To assess the effect of formalin on genomic DNA and assay performance for som...
What is the impact of assay failure in your laboratory and how do you monitor for it?
Application of Companion Diagnostics - driving better treatment for cancer patients
Extraction of Nucleic Acid From FFPE Tissue Samples
Ambion scientists Emily Zeringer and Marie Gonzalez presented the background, methods and what to expect when extracting nucleic acids from FFPE tissue samples. These are the slides from the presentation. The presentation can be viewed with audio here http://find.lifetechnologies.com/ambion/ffpewebinar/sldshr
Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...
Participate in the interactive webinar: http://bit.ly/CHOZNWebinar
In this case study, we will present how we support our clients thanks to advantages provided by the CHOZN® Cell Line, and a specific strategy for clone selection where semi-automation and pool selection are leveraged, to get upstream right first time.
Explore our webinar library: www.emdmillipore.com/webinars
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
View our webinar here: https://bit.ly/2lKNdWX
Many different impurities are present in or generated during biotherapy manufacturing. This webinar will address how process contaminates can arise from raw input materials, occur as residual processing agents, or form as reaction by-products. We will review strategies within product characterization to de-risk the manufacturing process, including the use of routine and high complexity assays; and the recommended testing to meet regulatory requirements for clinical submission. Learn methods to avoid costly pitfalls and implement procedures to expedite product quality decisions at critical junctures in your development plan. We will discuss two types of therapies:
Cell & Gene Therapies
Polyethylenimine (PEI) is a transfection agent used in nearly all cell and gene therapy products. We will review the regulations and the liquid chromatography with charged aerosol detection (LC-CAD) methodology to demonstrate PEI removal during the production process.
Monoclonal Antibodies (mAb) and Cell & Gene Therapies
During mAb manufacturing and inherent to Cell & Gene Therapies, a significant proportion of process impurities arise from the host cell used to express the drug. Host cell protein (HCP) impurities, present at PPM-levels, are a major immunogenicity risk because they can elicit an unpredictable immune response in patients. We will review why their complex and diverse nature makes them challenging to monitor, and theho best practices, specifically HCP identification by mass spectrometry, for detection.
Learning points:
1. Accurate detection and characterization of residual PEI in cell and gene therapy products
2. Effective detection and characterization of residual host cell proteins (HCP) in mAbs
3. Available technology and assays for quantifying process impurities
4. Current regulatory requirements for detecting, quantifying, and removing process impurities during biotherapy manufacturing
A Turn-Key Flow-Through-Mode Purification Process to improve Quality and Safe...
In this webinar, you will learn:
Intensified plasma Immunoglobulin purifications
Scalable process development with latest technologies
Improved safety and quality of plasma IgG meeting required quality attributes
Detailed description:
Plasma-derived immunoglobulins (IgG) are essential medicines that are in worldwide shortage. How to develop optimized processing steps for robust and efficient manufacturing has been a constant goal, to make the most out of the precious plasma raw material.
In this study, we present a worse-case equivalent of plasma intermediate, explore various process steps along the fractionation flow, including flow-through-mode chromatography, affinity chromatography, virus inactivation steps and removal of solvent/detergent, single-pass TFF (SPTFF), clarification, and aseptic filtration, to establish a robust, easy-to-operate, readily scalable plasma IgG process with over 99% purity, depletion of IgA, isoagglutinin, and thrombogenic markers, meeting the commonly required 20% concentration for subcutaneous IgG infusion. Such solutions would be appropriate for various IgG intermediates which help to improve the global supply of immunoglobulins.
How to reach High Plasma Protein Concentration with Single-Pass TFF
This webinar will discuss our collaboration with Takeda on the development of a single-pass TFF system as an alternative to traditional TFF for concentrating a plasma-derived IgG solution.
Single-Pass Tangential Flow Filtration (SPTFF) is a technology that requires only one pass through the filter assembly to achieve the desired concentration with no recirculation of product.
SPTFF can offer many advantages in downstream processing, such as:
• Increased capacity and reduced process time
• Increased yield and product recovery
• Optimized processing of highly shear-sensitive products
• Reduced foam formation
• Reduced cost of goods
This presentation will cover our collaboration with Takeda, formerly Shire, for the development of a specific SPTFF system as an alternative to traditional TFF for concentrating a plasma-derived Immunoglobulin G (IgG) solution from 10% to 20%. Due to promising results, plans are underway to replace the currently used batch TFF process with a SPTFF step.
In this webinar, we will discuss:
- A comparison of traditional TFF versus SPTFF
- Design of Experiments (DOE) approach toward initial process development work and determination of the optimal parameters
- Process run results, including final product yield and product quality
Application and Adaptation of Platform and Alternative Purification Steps to ...
This document discusses challenges in applying standard platform purification processes to Fc-fusion proteins. Fc-fusion proteins show more diversity than monoclonal antibodies, which can complicate rapid process development. Residue levels and yields after protein A capture can vary significantly depending on cell line and molecule properties. Alternative viral inactivation or protein A wash steps may be required. Anion exchange chromatography may require bind-and-elute mode rather than flow-through for some molecules. Ultrafiltration/diafiltration can cause unexpected pH offsets at low protein concentrations for some Fc-fusions due to Donnan and volume exclusion effects. Overcoming these challenges may require modified purification steps or formulation conditions.
Mutation pp
qBiomarker Somatic Mutation PCR Arrays are panels of real-time PCR assays that allow for sensitive detection of mutations in 85-370 genes from fresh or FFPE samples. They provide detection of cancer-associated mutations with superior sensitivity compared to other methods using a simple real-time PCR protocol. The document describes the workflow which involves extracting DNA from samples, mixing with mastermix, distributing across the PCR array plate, running on a real-time PCR instrument, and analyzing data to make mutation calls. Examples of available arrays are provided that focus on different cancer types and pathways.
Challenges of FFPE Sample Materials – Where Does Variation in Quantity of Pur...
In this slidedeck, we reveal how to get the most from your FFPE samples. We discuss variability in quantity and purity of DNA purified from FFPE samples manually or with automated procedures, assessed by different quantification and quality control methods. You can also learn more about the QIAxpert system and how it can help you gain reliable quantification of FFPE samples.
ReaMetrix Hiv Reagent Portfolio
This document discusses affordable reagent alternatives for CD4 T-lymphocyte counting and HIV viral load testing in resource-poor settings. It introduces several reagents developed by ReaMetrix for CD4 enumeration on various flow cytometry platforms, including single- and multi-color reagents for common platforms like BD FACScan, BD FACSCalibur, and Guava. The reagents aim to provide accurate CD4 testing through simple workflow and are extensively validated. ReaMetrix also develops customized solutions and continues to expand platform compatibility.
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
Originally presented at the HIV Vaccine Manufacturing Workshop –July 19th& 20th, 2017 by Abhinav A. Shukla, Ph.D.Senior Vice PresidentDevelopment & ManufacturingKBI Biopharma, Durham NC
Cell Line Development: Reducing timelines and increasing titres
Cell line development: Reducing timelines and increasing titres by identification of host cell lines with improved characteristics. To develop a mammalian expression platform which rapidly leads to efficient, robust and high quality biomanufacturing processes
8 Challenges to Successful One-Step RT-PCR
The document discusses eight common challenges to successful one-step RT-PCR and how the new QIAGEN OneStep Ahead RT-PCR Kit addresses each challenge. The kit contains optimized components that allow reverse transcription and PCR amplification to take place in a single tube without extra optimization. It ensures efficient, highly specific reactions with convenient room temperature setup and a visual pipetting control. The kit also offers the fastest cycling protocol on the market by completing the one-step RT-PCR in just one hour.
Linkedin Gen Script
GenScript is a world-leading biology CRO with over 1,000 employees and facilities in New Jersey, Nanjing, Paris, and Tokyo. It provides a range of custom biology services including gene synthesis, protein expression, antibody production, and assay development to support drug discovery. GenScript has significant production capacity and aims to remove bottlenecks in early-stage drug development through its integrated service offerings.
Advancing Microbiome Research: From challenging samples to insight with Confi...
This document discusses QIAGEN's products for microbiome research including sample preparation kits, automation, next-generation sequencing (NGS) library preparation kits, and data analysis software. It highlights two key innovations in their sample prep kits: optimized bead beating for tough sample lysis and inhibitor removal technology to purify nucleic acids. A range of kits are available for isolating DNA and RNA from difficult sample types like soil, water, biofilms, and stool. Library preparation kits make NGS accessible and several kits are compatible with QIAcube for automated sample prep. Data analysis software assists with comparative microbiome profiling and assembly.
ReaMetrix Overview
ReaMetrix is a life science technology company founded in 2003 with facilities in San Carlos, CA and Bangalore, India. It is committed to developing high-quality, affordable diagnostic solutions for resource-limited settings. ReaMetrix has expertise in assay development, protein expression and labeling, instrumentation, and developing integrated diagnostic solutions. It currently offers products like conjugates for flow cytometry-based tests and is working on projects like affordable point-of-care tests for bacterial detection and disease monitoring.
Recombinant Fab fragments specific for the pfHRPII and pfHSP72 : implications...
Recombinant Fab fragments specific for the pfHRPII and pfHSP72 : implications...Institut Pasteur de Madagascar
Recombinant Fab fragments specific for the pfHRPII and pfHSP72 : implications for malaria diagnosis - Parole de junior de la 7e édition du Cours international « Atelier Paludisme » - Ravaoarisoa Elisabeth - Madagascar - elisa@pasteur.mgCancer Research & the Challenges of FFPE Samples – An Introduction
A cascade of complex genetic and epigenetic changes regulate tumor formation and progression. Gene expression analyses can shed light on these changes at a molecular level and identify the key genes and associated pathways involved in cancer. Often the samples used in cancer research are FFPE samples, which pose a significant challenge in terms of nucleic acid quality. The quality of nucleic acids extracted from FFPE samples depends on a number of factors, including how the samples were handled before, during and after fixation and embedding.
Dr. Vishwadeepak Tripathi describes the variability of sample purification from FFPE samples – in particular, samples to be used in cancer research. What are the challenges and solutions, and what quality control approach can ensure credible results? This webinar will focus on sample purification and the quality control of FFPE samples and compare different automated purification procedures.
Setting up for successful lot release testing by Edmund Ang
Is your lot release testing strategy ready for global commercialization?
In this webinar, you will learn:
• CMC testing requirements with CHO production platform for global commercialization
• Lot release testing of product intermediates and final product
• Product-specific qualification study
• Alternative rapid testing methods to advance lot release testing
CHO cells continue to serve as a key cell substrate for the manufacturing of recombinant proteins that span beyond therapeutic monoclonal antibodies and including subunit vaccines.
In this presentation, we will cover the CMC testing requirements with CHO production platform for global commercialization, Lot release testing of product intermediates and final product, product-specific qualification study and highlight the application of new testing methods and the benefits they bring to advance Lot Release Testing.
Sucrose low in nanoparticulate impurities for biopharmaceutical formulations
1) The document describes a study to develop a purification process to reduce nanoparticle impurities (NPIs) in sucrose and analyze differences between NPIs from beet- and cane-derived sucrose.
2) Methods like DLS, NTA, and zeta potential analysis show that beet-derived NPIs have a more negative charge and greater impact on protein stability than cane-derived NPIs.
3) A purification method was successfully developed to reduce NPIs in sucrose and launch Sucrose Emprove® Expert, shown to significantly decrease particle concentration compared to non-purified raw materials.
Mohit Patel -- Disruptive Diner: Nano Possibilities
Presentation from 10/15/13 on innovative startup producing cost effective nano particle kits to get large amounts of DNA into cells without damaging them. Genetix Fusion LLC founder Mohit Patel explains how nanotech makes this possible and the enormous time and cost problems they're able to address. Join OpenlyDisruptive.org for live access to more disruptive innovation events.
Linkedin Gen Script
GenScript is a world-leading biology CRO with over 1,000 employees and facilities in New Jersey, Nanjing, Paris, and Tokyo. It provides custom gene synthesis, protein and peptide services, antibodies, and assay development. GenScript has a drug discovery platform and removes bottlenecks in early drug discovery through custom bio-reagent preparation and screening.
Aptamer development-platform
a full range of complement therapeutic services and complement based drug discovery services for customers at https://www.creative-biolabs.com/complement-therapeutics/
More Related Content
What's hot
Extraction of Nucleic Acid From FFPE Tissue Samples
Ambion scientists Emily Zeringer and Marie Gonzalez presented the background, methods and what to expect when extracting nucleic acids from FFPE tissue samples. These are the slides from the presentation. The presentation can be viewed with audio here http://find.lifetechnologies.com/ambion/ffpewebinar/sldshr
Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...
Participate in the interactive webinar: http://bit.ly/CHOZNWebinar
In this case study, we will present how we support our clients thanks to advantages provided by the CHOZN® Cell Line, and a specific strategy for clone selection where semi-automation and pool selection are leveraged, to get upstream right first time.
Explore our webinar library: www.emdmillipore.com/webinars
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
View our webinar here: https://bit.ly/2lKNdWX
Many different impurities are present in or generated during biotherapy manufacturing. This webinar will address how process contaminates can arise from raw input materials, occur as residual processing agents, or form as reaction by-products. We will review strategies within product characterization to de-risk the manufacturing process, including the use of routine and high complexity assays; and the recommended testing to meet regulatory requirements for clinical submission. Learn methods to avoid costly pitfalls and implement procedures to expedite product quality decisions at critical junctures in your development plan. We will discuss two types of therapies:
Cell & Gene Therapies
Polyethylenimine (PEI) is a transfection agent used in nearly all cell and gene therapy products. We will review the regulations and the liquid chromatography with charged aerosol detection (LC-CAD) methodology to demonstrate PEI removal during the production process.
Monoclonal Antibodies (mAb) and Cell & Gene Therapies
During mAb manufacturing and inherent to Cell & Gene Therapies, a significant proportion of process impurities arise from the host cell used to express the drug. Host cell protein (HCP) impurities, present at PPM-levels, are a major immunogenicity risk because they can elicit an unpredictable immune response in patients. We will review why their complex and diverse nature makes them challenging to monitor, and theho best practices, specifically HCP identification by mass spectrometry, for detection.
Learning points:
1. Accurate detection and characterization of residual PEI in cell and gene therapy products
2. Effective detection and characterization of residual host cell proteins (HCP) in mAbs
3. Available technology and assays for quantifying process impurities
4. Current regulatory requirements for detecting, quantifying, and removing process impurities during biotherapy manufacturing
A Turn-Key Flow-Through-Mode Purification Process to improve Quality and Safe...
In this webinar, you will learn:
Intensified plasma Immunoglobulin purifications
Scalable process development with latest technologies
Improved safety and quality of plasma IgG meeting required quality attributes
Detailed description:
Plasma-derived immunoglobulins (IgG) are essential medicines that are in worldwide shortage. How to develop optimized processing steps for robust and efficient manufacturing has been a constant goal, to make the most out of the precious plasma raw material.
In this study, we present a worse-case equivalent of plasma intermediate, explore various process steps along the fractionation flow, including flow-through-mode chromatography, affinity chromatography, virus inactivation steps and removal of solvent/detergent, single-pass TFF (SPTFF), clarification, and aseptic filtration, to establish a robust, easy-to-operate, readily scalable plasma IgG process with over 99% purity, depletion of IgA, isoagglutinin, and thrombogenic markers, meeting the commonly required 20% concentration for subcutaneous IgG infusion. Such solutions would be appropriate for various IgG intermediates which help to improve the global supply of immunoglobulins.
How to reach High Plasma Protein Concentration with Single-Pass TFF
This webinar will discuss our collaboration with Takeda on the development of a single-pass TFF system as an alternative to traditional TFF for concentrating a plasma-derived IgG solution.
Single-Pass Tangential Flow Filtration (SPTFF) is a technology that requires only one pass through the filter assembly to achieve the desired concentration with no recirculation of product.
SPTFF can offer many advantages in downstream processing, such as:
• Increased capacity and reduced process time
• Increased yield and product recovery
• Optimized processing of highly shear-sensitive products
• Reduced foam formation
• Reduced cost of goods
This presentation will cover our collaboration with Takeda, formerly Shire, for the development of a specific SPTFF system as an alternative to traditional TFF for concentrating a plasma-derived Immunoglobulin G (IgG) solution from 10% to 20%. Due to promising results, plans are underway to replace the currently used batch TFF process with a SPTFF step.
In this webinar, we will discuss:
- A comparison of traditional TFF versus SPTFF
- Design of Experiments (DOE) approach toward initial process development work and determination of the optimal parameters
- Process run results, including final product yield and product quality
Application and Adaptation of Platform and Alternative Purification Steps to ...
This document discusses challenges in applying standard platform purification processes to Fc-fusion proteins. Fc-fusion proteins show more diversity than monoclonal antibodies, which can complicate rapid process development. Residue levels and yields after protein A capture can vary significantly depending on cell line and molecule properties. Alternative viral inactivation or protein A wash steps may be required. Anion exchange chromatography may require bind-and-elute mode rather than flow-through for some molecules. Ultrafiltration/diafiltration can cause unexpected pH offsets at low protein concentrations for some Fc-fusions due to Donnan and volume exclusion effects. Overcoming these challenges may require modified purification steps or formulation conditions.
Mutation pp
qBiomarker Somatic Mutation PCR Arrays are panels of real-time PCR assays that allow for sensitive detection of mutations in 85-370 genes from fresh or FFPE samples. They provide detection of cancer-associated mutations with superior sensitivity compared to other methods using a simple real-time PCR protocol. The document describes the workflow which involves extracting DNA from samples, mixing with mastermix, distributing across the PCR array plate, running on a real-time PCR instrument, and analyzing data to make mutation calls. Examples of available arrays are provided that focus on different cancer types and pathways.
Challenges of FFPE Sample Materials – Where Does Variation in Quantity of Pur...
In this slidedeck, we reveal how to get the most from your FFPE samples. We discuss variability in quantity and purity of DNA purified from FFPE samples manually or with automated procedures, assessed by different quantification and quality control methods. You can also learn more about the QIAxpert system and how it can help you gain reliable quantification of FFPE samples.
ReaMetrix Hiv Reagent Portfolio
This document discusses affordable reagent alternatives for CD4 T-lymphocyte counting and HIV viral load testing in resource-poor settings. It introduces several reagents developed by ReaMetrix for CD4 enumeration on various flow cytometry platforms, including single- and multi-color reagents for common platforms like BD FACScan, BD FACSCalibur, and Guava. The reagents aim to provide accurate CD4 testing through simple workflow and are extensively validated. ReaMetrix also develops customized solutions and continues to expand platform compatibility.
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
Originally presented at the HIV Vaccine Manufacturing Workshop –July 19th& 20th, 2017 by Abhinav A. Shukla, Ph.D.Senior Vice PresidentDevelopment & ManufacturingKBI Biopharma, Durham NC
Cell Line Development: Reducing timelines and increasing titres
Cell line development: Reducing timelines and increasing titres by identification of host cell lines with improved characteristics. To develop a mammalian expression platform which rapidly leads to efficient, robust and high quality biomanufacturing processes
8 Challenges to Successful One-Step RT-PCR
The document discusses eight common challenges to successful one-step RT-PCR and how the new QIAGEN OneStep Ahead RT-PCR Kit addresses each challenge. The kit contains optimized components that allow reverse transcription and PCR amplification to take place in a single tube without extra optimization. It ensures efficient, highly specific reactions with convenient room temperature setup and a visual pipetting control. The kit also offers the fastest cycling protocol on the market by completing the one-step RT-PCR in just one hour.
Linkedin Gen Script
GenScript is a world-leading biology CRO with over 1,000 employees and facilities in New Jersey, Nanjing, Paris, and Tokyo. It provides a range of custom biology services including gene synthesis, protein expression, antibody production, and assay development to support drug discovery. GenScript has significant production capacity and aims to remove bottlenecks in early-stage drug development through its integrated service offerings.
Advancing Microbiome Research: From challenging samples to insight with Confi...
This document discusses QIAGEN's products for microbiome research including sample preparation kits, automation, next-generation sequencing (NGS) library preparation kits, and data analysis software. It highlights two key innovations in their sample prep kits: optimized bead beating for tough sample lysis and inhibitor removal technology to purify nucleic acids. A range of kits are available for isolating DNA and RNA from difficult sample types like soil, water, biofilms, and stool. Library preparation kits make NGS accessible and several kits are compatible with QIAcube for automated sample prep. Data analysis software assists with comparative microbiome profiling and assembly.
ReaMetrix Overview
ReaMetrix is a life science technology company founded in 2003 with facilities in San Carlos, CA and Bangalore, India. It is committed to developing high-quality, affordable diagnostic solutions for resource-limited settings. ReaMetrix has expertise in assay development, protein expression and labeling, instrumentation, and developing integrated diagnostic solutions. It currently offers products like conjugates for flow cytometry-based tests and is working on projects like affordable point-of-care tests for bacterial detection and disease monitoring.
Recombinant Fab fragments specific for the pfHRPII and pfHSP72 : implications...
Recombinant Fab fragments specific for the pfHRPII and pfHSP72 : implications...Institut Pasteur de Madagascar
Recombinant Fab fragments specific for the pfHRPII and pfHSP72 : implications for malaria diagnosis - Parole de junior de la 7e édition du Cours international « Atelier Paludisme » - Ravaoarisoa Elisabeth - Madagascar - elisa@pasteur.mgCancer Research & the Challenges of FFPE Samples – An Introduction
A cascade of complex genetic and epigenetic changes regulate tumor formation and progression. Gene expression analyses can shed light on these changes at a molecular level and identify the key genes and associated pathways involved in cancer. Often the samples used in cancer research are FFPE samples, which pose a significant challenge in terms of nucleic acid quality. The quality of nucleic acids extracted from FFPE samples depends on a number of factors, including how the samples were handled before, during and after fixation and embedding.
Dr. Vishwadeepak Tripathi describes the variability of sample purification from FFPE samples – in particular, samples to be used in cancer research. What are the challenges and solutions, and what quality control approach can ensure credible results? This webinar will focus on sample purification and the quality control of FFPE samples and compare different automated purification procedures.
Setting up for successful lot release testing by Edmund Ang
Is your lot release testing strategy ready for global commercialization?
In this webinar, you will learn:
• CMC testing requirements with CHO production platform for global commercialization
• Lot release testing of product intermediates and final product
• Product-specific qualification study
• Alternative rapid testing methods to advance lot release testing
CHO cells continue to serve as a key cell substrate for the manufacturing of recombinant proteins that span beyond therapeutic monoclonal antibodies and including subunit vaccines.
In this presentation, we will cover the CMC testing requirements with CHO production platform for global commercialization, Lot release testing of product intermediates and final product, product-specific qualification study and highlight the application of new testing methods and the benefits they bring to advance Lot Release Testing.
Sucrose low in nanoparticulate impurities for biopharmaceutical formulations
1) The document describes a study to develop a purification process to reduce nanoparticle impurities (NPIs) in sucrose and analyze differences between NPIs from beet- and cane-derived sucrose.
2) Methods like DLS, NTA, and zeta potential analysis show that beet-derived NPIs have a more negative charge and greater impact on protein stability than cane-derived NPIs.
3) A purification method was successfully developed to reduce NPIs in sucrose and launch Sucrose Emprove® Expert, shown to significantly decrease particle concentration compared to non-purified raw materials.
Mohit Patel -- Disruptive Diner: Nano Possibilities
Presentation from 10/15/13 on innovative startup producing cost effective nano particle kits to get large amounts of DNA into cells without damaging them. Genetix Fusion LLC founder Mohit Patel explains how nanotech makes this possible and the enormous time and cost problems they're able to address. Join OpenlyDisruptive.org for live access to more disruptive innovation events.
What's hot (20)
Extraction of Nucleic Acid From FFPE Tissue Samples
Extraction of Nucleic Acid From FFPE Tissue Samples
Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...
Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell...
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
A Turn-Key Flow-Through-Mode Purification Process to improve Quality and Safe...
A Turn-Key Flow-Through-Mode Purification Process to improve Quality and Safe...
How to reach High Plasma Protein Concentration with Single-Pass TFF
How to reach High Plasma Protein Concentration with Single-Pass TFF
Application and Adaptation of Platform and Alternative Purification Steps to ...
Application and Adaptation of Platform and Alternative Purification Steps to ...
Challenges of FFPE Sample Materials – Where Does Variation in Quantity of Pur...
Challenges of FFPE Sample Materials – Where Does Variation in Quantity of Pur...
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
Cell Line Development: Reducing timelines and increasing titres
Cell Line Development: Reducing timelines and increasing titres
Advancing Microbiome Research: From challenging samples to insight with Confi...
Advancing Microbiome Research: From challenging samples to insight with Confi...
Recombinant Fab fragments specific for the pfHRPII and pfHSP72 : implications...
Recombinant Fab fragments specific for the pfHRPII and pfHSP72 : implications...
Cancer Research & the Challenges of FFPE Samples – An Introduction
Cancer Research & the Challenges of FFPE Samples – An Introduction
Setting up for successful lot release testing by Edmund Ang
Setting up for successful lot release testing by Edmund Ang
Sucrose low in nanoparticulate impurities for biopharmaceutical formulations
Sucrose low in nanoparticulate impurities for biopharmaceutical formulations
Mohit Patel -- Disruptive Diner: Nano Possibilities
Mohit Patel -- Disruptive Diner: Nano Possibilities
Similar to Kinase assays
Linkedin Gen Script
GenScript is a world-leading biology CRO with over 1,000 employees and facilities in New Jersey, Nanjing, Paris, and Tokyo. It provides custom gene synthesis, protein and peptide services, antibodies, and assay development. GenScript has a drug discovery platform and removes bottlenecks in early drug discovery through custom bio-reagent preparation and screening.
Aptamer development-platform
a full range of complement therapeutic services and complement based drug discovery services for customers at https://www.creative-biolabs.com/complement-therapeutics/
Somatic mutation webinar
This document provides information about qBiomarker somatic mutation PCR arrays for cancer mutation analysis. It discusses how the arrays can detect mutations in key cancer genes and pathways. The document outlines the workflow, which involves using quantitative PCR to detect mutations in DNA samples. Data is analyzed by comparing Ct values between mutation assays and controls to identify which samples contain mutations. The document provides examples of this analysis method using lung and colon cancer cell line and patient samples.
Chromatrap presentation 2016
Chromatrap® is able to reduce the time spent in the laboratory by minimising the need for manual handling. By reducing the time spent using a pipette and with no incubation required, it means that results are achieved faster.
Eliapharma Brochure
Eliapharma Services Inc. is a Canadian CRO that provides bioanalytical and preclinical services to support all stages of drug discovery and development for biotechs, pharmaceutical companies, CROs, researchers, and hospitals. They offer personalized services including method development, validation, sample analysis, metabolism studies, toxicology studies, and imaging using state-of-the-art technology with experienced employees at a competitive cost.
Bioanalytical & Biomarker Capabilities
KCAS Bioanalytical Services is a contract research organization that provides bioanalytical and immunoanalytical services to support pharmaceutical and biotechnology companies. They have over 35 years of experience producing reliable and high quality results for small molecule, large molecule, and biomarker analysis. Their services include method development, validation, sample analysis, and clinical trial support for global studies. They have state-of-the-art facilities and equipment, including multiple LC-MS/MS systems and immunoassay instruments located in a 33,000 square foot laboratory near Kansas City.
Bioeast Company Profile.pdf
Hangzhou Bioeast Biotech is a biomedical materials company with over 300 employees across 4 subsidiaries. It develops and manufactures over 100 products including enzymes, cytokines, antibodies/antigens, and magnetic microbeads. It has over 25 patents and spends $3 million annually on R&D. The company and its subsidiaries have ISO13485 and GMP certifications and facilities in China and Singapore.
GMO Analysis
Midwest Laboratories has 40 years of experience providing a broad spectrum of testing services for environmental, food, feed, and fuel samples. They operate from a single central location and serve clients throughout the US. The company prides itself on quality, service, and innovation through new testing methods and state-of-the-art equipment. Midwest Laboratories now offers genetically modified organism (GMO) testing using droplet digital PCR, which provides absolute quantification, high sensitivity, and low detection levels at a reduced cost to clients.
AssayQuant Technologies, Inc.
Our initial focus is to develop innovative strategies for directly measuring the activity of protein kinases, which transfer a phosphate group from ATP to serine, threonine or tyrosine residues within protein or peptide substrates. There are over 500 protein kinases and this group of enzymes is intensely studied since dysregulation of kinase activities lies at the center of many human diseases. Generation of protein kinase inhibitors and the need to accurately measure kinase activities in basic research, drug development and diagnostic applications is an active area that spans many markets including pharmaceutical, biotechnology, diagnostic and contract research companies, and academic and Government institutions. There has been a surge in the generation of non-ATP-competitive kinase inhibitors, with an increased need for better assay tools to effectively characterize their mechanism of action and drive decisions earlier in the drug development process.
Biochain PCR Products
The document discusses BioChain's products for PCR and sample preparation, including PCR enzymes, reverse transcriptases, master mixes, dNTPs, and supporting reagents. It provides details on BioChain's Taq DNA polymerase and Hot Start Taq DNA polymerase, which are produced under strict quality control. It also describes BioChain's UltraScript reverse transcriptase, which is ideal for cDNA synthesis of templates with secondary structure or high GC content. Furthermore, it mentions BioChain's pre-mixed master mixes for standard and quantitative PCR, which offer convenience and reproducibility.
Cignal webina
The document describes Cignal Reporter Assays from SABiosciences that enable simple and robust analysis of signal transduction pathways. The assays utilize dual-luciferase reporters containing optimized transcriptional regulatory elements and luciferase variants to provide high sensitivity and low variability. The assays allow monitoring of 29 pathways and are available in different formats for various cell types and applications like RNAi and small molecule screening.
Ai Biotech Mktg Overview 0411
AI Biotech is a contract research organization that provides integrated project support for biologics and specialty diagnostic development. It focuses on early stage discovery and development with services including target identification, pre-clinical testing, clinical testing, and client CROs. AI Biotech has over 70 employees, including 70% scientists, operates a 32,000 square foot GLP compliant facility, and has served over 5,500 clients worldwide.
Mtr corporate
Micro Therapeutic Research Labs Private Limited is an integrated service provider for pharma and biotech companies. It has facilities across India including in Selaiyur, Coimbatore, Chrompet, and Padi, Chennai. The facilities include clinical pharmacology units, bioanalytical labs, preclinical and biology labs, and are GLP compliant. The company provides services across the drug development spectrum from preclinical research to clinical trials to regulatory submissions. It has experience conducting over 1000 bioavailability and bioequivalence studies for clients globally.
Genscript overview 030110[1]
GenScript is a biotechnology company founded in 2002 that provides gene synthesis, protein and antibody services. It has over 800 employees across facilities in the US, China, France and Japan. GenScript is the largest provider of custom gene synthesis in the US and offers services including gene synthesis, cloning, mutagenesis, and plasmid preparation. It also provides protein and antibody services such as expression, purification, production and development of monoclonal and polyclonal antibodies. GenScript focuses on intellectual property protection and being a reliable partner for its clients in the pharmaceutical and biotech industries.
Genscript Overview
GenScript is a biotechnology company founded in 2002 that provides gene synthesis, protein and antibody services. It has over 800 employees across facilities in the US, China, France and Japan. GenScript is the largest provider of custom gene synthesis in the US and offers services including gene synthesis, cloning, mutagenesis, and plasmid preparation. It also provides protein and antibody services such as expression, purification, production and development of monoclonal and polyclonal antibodies. GenScript focuses on intellectual property protection and being a reliable partner for its pharmaceutical and biotech clients.
KO-brochure-online-jan2015-hi
Key Organics is a UK-based contract research organization with over 28 years of experience in synthetic organic chemistry. They provide integrated drug discovery and development services from hit identification through pre-clinical development. Their services include custom synthesis, focused library design and synthesis using in-house fragment libraries and computational tools, hit-to-lead and lead optimization chemistry, process research and development, and delivery of pre-clinical batches. They emphasize transparent communication with customers and flexibility to adapt to changing project needs and timelines.
API Supply
Almac provides chemistry and manufacturing solutions for APIs from discovery through commercialization. They offer multi-purpose GMP manufacturing facilities, process R&D, preclinical through commercial API supply, analytical development and validation, potent API production, biotransformation, micronization, and process validation using quality by design approaches. Almac has expertise in chemical development, biocatalysis, physical sciences, formulation development, and analytical services to support clients' API needs.
Liquid biopsy RNA biomarkers
September 14, 2016 - Biogazelle’s CEO dr Jan Hellemans presented Biogazelle’s strategy and expertise to deploy RNA in liquid biopsies to further diagnostic applications and drug development at the “Nordic Life Science days 2016” (Stockholm, Sweden).
Accelerate Your Discovery with QIAGEN Service Solutions for Biomarker Researc...
This slidedeck will highlight QIAGEN’s service capabilities in sample isolation, microarray and NGS-sequencing, qPCR panel and custom assay development and bioinformatics as we look at the identification of potential biomarkers and gene signatures. The applications of QIAGEN Service Core in microRNA discovery for toxicology markers in serum and plasma and in identification of RNA signatures for tumor stratification are featured. Learn how you can accelerate your research with QIAGEN service solutions.
Efrac drug brochure
EFRAC is an ISO 17025 accredited pharmaceutical testing facility located in Chennai, India. It has 11 regulatory accreditations and conducts a wide range of tests for drugs, cosmetics, and related products according to international standards. EFRAC utilizes cutting-edge technology and qualified instrumentation to provide precise, reliable, and legally defensible testing data to clients.
Similar to Kinase assays (20)
Accelerate Your Discovery with QIAGEN Service Solutions for Biomarker Researc...
Accelerate Your Discovery with QIAGEN Service Solutions for Biomarker Researc...
More from Bennie George
Rna sequencing of cardiac cells may elucidate cardiac developmental mechanism...
In animal studies, researchers identified multiple cell types in healthy and diseased hearts, and researchers also studied the ‘transcription blueprint’ in detail, where DNA transcribes genetic information into RNA and protein.
https://www.creative-bioarray.com/products/adult-stem-cells-34.htm
The Complete Guide to Know That RNA Sequencing of Cardiac Cells May Elucidate...
A research report published in the international magazine Genes & Development, scientists from the Children's Hospital of Philadelphia used a powerful new technology to RNA sequence 20,000 single nuclei, opening up the biological events behind heart disease.
https://www.creative-bioarray.com/services/stem-cell-research.htm
Epithelial cells
Epithelial cells from Creative Bioarray have been isolated from human normal, diseased donors of various tissues and animals such as mouse, rat, monkey and bovine with high purity, low passage, rigorously characterized, and performance tested.
https://www.creative-bioarray.com/filter/epithelial-cell-and-media-11.html
Cytokines & growth factors
Mouse Interleukin-13 (IL-13) is produced primarily by activated Th2 cells. IL-13 is a pleiotropic immune regulatory cytokine that promotes growth of human B cells; induces expression of germ line Ce transcripts, directs na?ve B cells to switch to the synthesis of IgE and IgG4, and induces expression of CD23 and Class II-MHC.
https://www.creative-bioarray.com/ActoFactor%E2%84%A2-Recombinant-Mouse-Interleukin-13-CSC-CTK0002-item-4204.htm
Cell tissue lysates
Creative Bioarray provides custom cell & tissue lysates service for all of our customers to meet their scientific requirements for downstream analysis. We provide different types of lysates from various species such as human, cynomolgus monkey, bovine, canine, mouse, rat, rabbit, ferret, zebrafish, and so on.
https://www.creative-bioarray.com/Services/custom-cell-tissue-lysates-service.htm
Fluorescent in situ hybridization
Fluorescence in situ hybridization (FISH), developed in 1980s, is a cytogenetic technique using fluorescent probes to bind the chromosome with a high degree of complementarity. It is a powerful and easy method to detect RNA or DNA sequences in cells, tissues and tumors.
https://www.creative-bioarray.com/services/Fluorescent-In-Situ-hybridization-FISH.htm
Ubiquitin
Ubiquitination is a key regulatory mechanism attaching the small protein modifier ubiquitin to protein substrates, thereby modifying their structure, cellular location, function, or targeting them for destruction via proteolysis.
https://www.creative-biogene.com/Services/Drug-Discovery-Services/Ubiquitin-Screening-Profiling-Services.html
Abc transporters family
Creative Biogene offers a wide range of ABC transporters assays, including P-gp (MDR1/ABCB1), BCRP (ABCG2) and BSEP (sPgp/ABCB11), etc.
https://www.creative-biogene.com/Services/Drug-Discovery-Services/ABC-transporters-Screening-and-Profilin-Assays.html
Dna methyltransferase screening
A methyl group from S-adenosyl-methionine (SAM) is transferred to the C5 position of the pyrimidine ring of cytosine residues by DNMTs in genomic CpG dinucleotides.
https://www.creative-biogene.com/Services/Drug-Discovery-Services/DNA-Methyltransferase-Screening-and-Profiling.html
Epigenetic service
Creative Biogene offers epigenetic screening and profiling services to help with drug discovery. Their scientists provide expertise in epigenetics to advance drug programs targeting epigenetic mechanisms. They have high-throughput and customized assays to screen compound libraries against epigenetic targets or profile a drug's activity against multiple targets. Epigenetics involves heritable gene expression changes not from DNA alterations, and impacts many disease areas making it important for diagnostics and therapeutics.
Oncology
Oncology is a branch of medicine that deals with the prevention, diagnosis and treatment of cancer. Research contains mechanism study (including molecule mechanism), pathological research, surgical method, medical treatment therapy (chemotherapy, radiotherapy), management for an individual patient, new drug development, etc. Obviously, oncology is often managed through discussion on multi-disciplinary.
https://www.creative-bioarray.com/oncology.htm
Herg safety assay
Creative Bioarray offers hERG safety assays conducted by experts to evaluate cardiovascular safety of compounds according to ICH S7B guidelines. The hERG assay tests inhibition of the potassium channel associated with prolonged QT interval and ventricular arrhythmias. Other ion channel inhibition assays are also available to support drug development and identify risks of delayed ventricular repolarization.
Epithelial cells
The principle function of epithelial cells is to provide a protective layer for the organ they enclose but also provide other biological functions including secretion, selective absorption, filtration, protection and detection of sensation.
https://www.creative-bioarray.com/filter/epithelial-cell-and-media-11.html
Virus packaging
Virus packaging is a kind of biological technology, which is developed from the characteristics of virus replication. In this technology, virus packages the target gene into the structural and non structural proteins to produce viruses which have certain infectivity but have no pathogenicity.
https://www.creative-biogene.com/Product/Virus-Packaging-Kits.html
New Findings in T cell Behavior Are Expected to Help Develop New Immunotherap...
Recently, a research report published in the international journal Science Immunology, scientists from the University of Colorado found that the disease-resistant T cells obtained from the vaccine may not need glucose to rapidly multiply, related research results may provide new ideas and hopes for the development of new immunotherapy for cancer patients.
https://www.creative-bioarray.com/immuno-oncology.htm
The Complete Guide to Know That New Findings in T cell Behavior Are Expected ...
The researchers analyzed patients who were vaccinated with subunit vaccines which are made with a portion of the disease virus to test the T cells produced in their immune systems. The researchers found that the key white blood cells (T cells) that attack and suppress infection do not rely on glucose to accelerate rapid cell division, the cell division will occur every 2-4 hours.
Baculovirus
Baculovirus-Insect cell expression system is one of the most popular eukaryotic expression systems for research and industrial applications. There are several advantages of using the baculovirus-Insect cell expression system, such as improved solubility, ability to incorporate post-translational modifications, and higher yield of secreted proteins.
https://www.creative-biogene.com/Services/Baculovirus-Insect-cell-expression-system.html
Ion channel
Ion channels are pore-forming membrane proteins that create a gated, water-filled pore to help establish and control voltage potential across cell membranes through control of the active flow of ions between the intracellular and the extracellular environments.
https://www.creative-biogene.com/Services/Drug-Discovery-Services/Ion-Channel-Screening-Assays.html
LAM PCR
LAM PCR (Linear - amplification mediated PCR) is a technology which is used for identifying and characterizing unknown flanking DNA adjacent to known DNA of any origin. More specifically, LAM-PCR has been developed to localize viral vector integration sites (IS) within the host genome.
crispr cas9 knockout
CRISPR/Cas9 system consists of a “guide” RNA (gRNA) and a bacterial CRISPR-associated endonuclease (Cas9). The gRNA is a short synthetic RNA composed of a Cas9-binding “scaffold” sequence and ∼20 nucleotide “targeting” sequence that defines the target genomic site to be modified.
https://www.creative-biogene.com/Services/Stable-cell-line-generation/Custom-Genome-Editing-Cell-Lines.html
More from Bennie George (20)
Rna sequencing of cardiac cells may elucidate cardiac developmental mechanism...
Rna sequencing of cardiac cells may elucidate cardiac developmental mechanism...
The Complete Guide to Know That RNA Sequencing of Cardiac Cells May Elucidate...
The Complete Guide to Know That RNA Sequencing of Cardiac Cells May Elucidate...
New Findings in T cell Behavior Are Expected to Help Develop New Immunotherap...
New Findings in T cell Behavior Are Expected to Help Develop New Immunotherap...
The Complete Guide to Know That New Findings in T cell Behavior Are Expected ...
The Complete Guide to Know That New Findings in T cell Behavior Are Expected ...
Recently uploaded
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxMGM SCHOOL/COLLEGE OF NURSING
Identification and nursing management of congenital malformations Histololgy of Female Reproductive System.pptx
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
The Electrocardiogram - Physiologic Principles
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Best Ayurvedic medicine for Gas and Indigestion
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...chandankumarsmartiso
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun Women Seeking Service
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...chandankumarsmartiso
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel With 100% Satisfaction
Efficacy of Avartana Sneha in Ayurveda
Avartana Sneha is a unique method of Preparation of Sneha Kalpana in Ayurveda, mainly it is indicated for the Vataja rogas.
Top-Vitamin-Supplement-Brands-in-India List
Swisschem Dermacare provides the Top 10 Vitamin Supplement Brands in India. To know more about us give us call at our official number
Role of Mukta Pishti in the Management of Hyperthyroidism
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
NVBDCP.pptx Nation vector borne disease control program
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
ABDOMINAL TRAUMA in pediatrics part one.
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Recently uploaded (20)
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
Kinase assays
- 2. Kinase with Biochemical Assays Creative Biogene is the leading company offering unmatched expertise and experience in kinase drug discovery. Our talent scientists provide the highest quality results efficiently with the most competitive price. Based on years of know-how in this field, Creative Biogene offers you best service in kinase biochemical assays. Creative Biogene offers filter-binding radiometric kinase activity assay, which has long been established as the most reliable, robust and gold standard assay against all other assay formats. We can also provide TR- FRET technology to measure substrate phosphorylation when a greater level of throughput is desired to support high throughput screens. Other assay formats, including Caliper, Luminescence, LC-MS, IMAP, ADP- Quest, etc, are also available in Creative Biogene.
- 4. Kinase with Biochemical Assays
- 5. Advantages of kinase assay services in Creative Biogene: . Fast turnaround time . Single dose measurement and IC50 determination . A broad range of panels for assay services . Unparalleled quality control . ATP concentrations selection, including Km and 10 μM, as your demands
- 6. Contact informationContact information Provider: Creative BiogeneCreative Biogene URL: https://www.creative-biogene.com/Services/Drug-Discovery-https://www.creative-biogene.com/Services/Drug-Discovery- Services/Kinase-Screening-and-Profiling-with-Biochemical-Assays.htmlServices/Kinase-Screening-and-Profiling-with-Biochemical-Assays.html Address: 45-1 Ramsey Road, Shirley, NY 11967, USA Phone No. 1-631-619-7922
- 7. Contact informationContact information Provider: Creative BiogeneCreative Biogene URL: https://www.creative-biogene.com/Services/Drug-Discovery-https://www.creative-biogene.com/Services/Drug-Discovery- Services/Kinase-Screening-and-Profiling-with-Biochemical-Assays.htmlServices/Kinase-Screening-and-Profiling-with-Biochemical-Assays.html Address: 45-1 Ramsey Road, Shirley, NY 11967, USA Phone No. 1-631-619-7922